Clozapine for the treatment of levodopa-induced psychosis in Parkinson's disease
β Scribed by Stephen H. Rosenthal; Martin L. Fenton; David S. Harnett
- Book ID
- 118386997
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 197 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0163-8343
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopaβinduced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5β25 mg daily, because
Cases of delayed or acute posttraumatic, therapy-resistant tremor have been previously described. [1][2][3][4] The onset is usually delayed (weeks to months/years), but they may also begin rapidly (within hours). Careful neuroradiologic examination may reveal small lesions, often in the deep brain a